Phase 1b study of intraperitoneal ipilimumab and nivolumab in patients with recurrent gynecologic malignancies with peritoneal carcinomatosisAnne Knisely, Amir A. Jazaeri, Kathryn Lito et al.|Med|2024Cited by 10
Intraperitoneal administration of dual immune checkpoint inhibitor therapy in recurrent gynecologic malignancies: Updated results of a phase 1b studyAnne Knisely, Amir A. Jazaeri, Emily Hinchcliff et al.|Gynecologic Oncology|2024Cited by 2